Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Relapse in recurrent unipolar depression.

D J Kupfer, E Frank

The American Journal of Psychiatry

|January 1, 1987

Summary

This summary is machine-generated.

Combined psychopharmacologic and psychotherapeutic treatment significantly reduced relapse rates in unipolar depression patients. This approach showed an 8.5% relapse rate, lower than other studies, indicating its effectiveness for recurrent depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.

The American journal of psychiatry·1999

Same author

Relationship between social rhythms and mood in patients with rapid cycling bipolar disorder.

Psychiatry research·1999

Same author

Diagnostic certainty of a voluntary bipolar disorder case registry.

Journal of affective disorders·1999

Same author

Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.

The American journal of psychiatry·1999

Same author

Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication.

Journal of psychiatric research·1999

Same author

Consensus criteria for traumatic grief. A preliminary empirical test.

The British journal of psychiatry : the journal of mental science·1999

Same journal

2026 Annual Meeting: President-Elect Address.

The American journal of psychiatry·2026

Same journal

2026 Annual Meeting: CEO and Medical Director's Address.

The American journal of psychiatry·2026

Same journal

Reports to the Membership.

The American journal of psychiatry·2026

Same journal

Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

The American journal of psychiatry·2026

Same journal

2026 Annual Meeting: Presidential Address.

The American journal of psychiatry·2026

Same journal

Represcribing Previously Used Antipsychotics: Response to So.

The American journal of psychiatry·2026

See all related articles

Area of Science:

Psychiatry
Clinical Psychology
Neuroscience

Background:

Recurrent depression treatment is established, yet relapse and recurrence remain significant challenges.
Existing treatments often struggle to adequately address long-term management of unipolar depression.

Purpose of the Study:

To evaluate the efficacy of a combined psychopharmacologic and psychotherapeutic approach for acute and continuation treatment of unipolar depression.
To assess the relapse rate in patients completing the continuation phase of this combined treatment.

Main Methods:

A cohort of unipolar depressed patients received combined psychopharmacologic and psychotherapeutic treatment.
The study monitored relapse rates after 8 weeks of recovery in patients who completed the continuation phase.

Related Experiment Videos

Main Results:

The combined treatment resulted in a relapse rate of 8.5% among 59 patients who finished the continuation phase.
This relapse rate is notably lower than the 15%-22% reported in other recent studies on recurrent depression.

Conclusions:

Combined psychopharmacologic and psychotherapeutic treatment offers advantages in managing recurrent unipolar depression.
This integrated approach appears to be more effective in preventing relapse compared to treatments studied previously.